8-K - IRulya Therapeutics Inc. (0001662774) (Filer)
Published . Updated .
Filed: 2026-10-19 AccNo: 0001193125-26-424731 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- IRLA IRulya Therapeutics
Named in this report.
- QNCX QUINCE THERAPEUTICS INC COM PA
SEC 8-K filing -> direct issuer disclosure -> QNCX
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-19 AccNo: 0001193125-26-424731 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Quince Therapeutics (QNCX)
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -1.14% | final price |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +1.04% | final price |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.75% | final price |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.11% | final price |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Who gains and who loses around Quince Therapeutics (QNCX)
Companies tied to this story
- QNCX Quince Therapeutics
In “8-K - IRulya Therapeutics Inc. (0001662774) (Filer),” Quince Therapeutics (QNCX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> QNCX
How “8-K - IRulya Therapeutics Inc. (0001662774) (Filer)” reaches Quince Therapeutics (QNCX)
Quince Therapeutics (QNCX) is the company in “8-K - IRulya Therapeutics Inc. (0001662774) (Filer),” the 19 Oct 2026 this story story.
What ties Quince Therapeutics (QNCX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> QNCX
The price range for Quince Therapeutics (QNCX), and the dates in the story
QNCX traded between 26.23 and 36.26 across 12 sessions. The latest close on file is 31.30.
What the saved facts support for Quince Therapeutics (QNCX)
14 out of 100
“8-K - IRulya Therapeutics Inc. (0001662774) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.